Nanomedicine for intracellular therapy

26Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Intracellular pathogens like Salmonella evade host phagocytic killing by various mechanisms. Classical antimicrobial therapy requires multiple dosages and frequent administration of drugs for a long duration. Intracellular delivery of antimicrobials using nanoparticle may effectively devise therapies for bacterial infections. This review will address the mechanisms used by Salmonella to avoid host pathogenic killing, reasons for therapeutic failure and advances in nanoparticle drug delivery technology for efficient intracellular bacterial clearance. © 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Ranjan, A., Pothayee, N., Seleem, M. N., Boyle, S. M., Kasimanickam, R., Riffle, J. S., & Sriranganathan, N. (2012). Nanomedicine for intracellular therapy. FEMS Microbiology Letters, 332(1), 1–9. https://doi.org/10.1111/j.1574-6968.2012.02566.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free